Performance data is updated to 31 May 2026.
iShares Nasdaq Top 30 ETF (ITEK) — Review & Analysis
ITEK is iShares' concentrated Nasdaq exposure — the 30 largest Nasdaq-listed names rather than the full 100 in NDQ. AUM is $9.60 million as at May 2026 with a 0.30% p.a. management fee — 18bp cheaper than NDQ but more concentrated. Compare ITEK across the tech cohort on our tech ETF page or use the Compare ETFs tool to put ITEK vs NDQ or FANG side-by-side.
ITEK occupies a middle ground between FANG (10 stocks equal-weighted) and NDQ (100 stocks market-cap weighted). The 30-stock count means ITEK captures the Nasdaq mega-caps that drive most of the index's returns (Apple, Microsoft, Nvidia, Amazon, Meta, Google, Tesla, Broadcom) plus the next tier of large-cap Nasdaq names — but excludes the bottom 70 stocks in NDQ that contribute less to performance.
The 0.30% fee positions ITEK as a low-cost concentrated tech option. Compared to U100 at 0.18% (the cheapest Nasdaq 100 tracker), ITEK is 12bp more expensive but offers concentrated exposure rather than full index breadth. For investors who specifically want the largest Nasdaq names without the diluting effect of smaller index members, ITEK is the natural choice.
ITEK is unhedged. The iShares brand provides additional credibility for adviser allocations seeking a concentrated US tech exposure. Our AI boom beyond NDQ guide covers ITEK alongside other concentrated and thematic tech options.
Performance (% return)
Investment Focus
Themes
Exposure Regions
Portfolio Breakdown
| Symbol | Company Name | % assets |
|---|---|---|
| QTOP | ISHARES NASDAQ TOP 30 STOCKS CL1 | 99.98% |
| USD | USD CASH | 0.03% |
| AUD | AUD CASH | -0.01% |
| Sector | % assets |
|---|---|
| Information Technology | 59.17% |
| Communication | 18.33% |
| Consumer Discretionary | 12.46% |
| Consumer Staples | 4.31% |
| Health Care | 4.08% |
| Materials | 1.51% |
| Cash and/or Derivatives | 0.13% |
| Other | 0.01% |
Similar ETFs
| Stock | Name | 1 Year % |
|---|---|---|
| BEST | ETFS US Quality ETF | +15.75% |
Disclaimer
The information provided on ReviewETF.com.au is intended for general information and comparison purposes only. It is compiled and presented on a best-endeavours basis from publicly available sources, but we do not guarantee its accuracy, completeness, timeliness, or suitability for any particular purpose.
No content on this website constitutes financial advice, investment recommendation, solicitation, or an offer to buy or sell any securities. Past performance is not indicative of future results, and all investments carry risk, including the potential loss of capital.
The point of truth for any ETF is always the official product disclosure statement (PDS), website, and announcements from the ETF issuer/provider (e.g., Vanguard, BetaShares, iShares, VanEck, etc.). We link directly to these primary sources on each individual ETF page wherever possible—please verify all details there before making any decisions.
ReviewETF.com.au, its owner (Joshua), and any associated entities disclaim all liability for any loss or damage arising from the use of, or reliance on, information contained on this site. Users should seek independent professional financial advice tailored to their personal circumstances.
This website may contain links to third-party sites; we are not responsible for their content or privacy practices.
Last updated: January 2026
